bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.07.24.501309

Early β-amyloid accumulation and hypoconnectivity in the default mode network are related to its disengagement from global brain activity

Abstract

AO_SCPLOWBSTRACTC_SCPLOWO_ST_ABSImportanceC_ST_ABSThe specific pattern/trajectory of {beta}-amyloid (A{beta}) pathology spreading in Alzheimers disease (AD), from default mode network (DMN) regions to sensory-motor areas, is well known, but poorly understood. ObjectiveTo determine if resting-state global brain activity is linked to early A{beta} deposition in the DMN. DesignThis is a retrospect analysis of multi-modal and longitudinal data from the Alzheimers disease Neuroimaging Initiative (ADNI) cohort. SettingThe ADNI was a multicenter project involving 63 research centers. ParticipantsThe study included 144 participants (72.6 {+/-} 7.5 years; 73 females) of whom 28 were controls, 21 had significant memory concerns, 72 had cognitive impairment (N=72), and 23 had AD. There were both baseline and 2-year follow-up data for A{beta}-PET for 112 of the subjects. They were classified into following stages based on the CSF A{beta}42 (CSF+: <192 ng/L) and cortical A{beta} (PET+: >0.872 SUVR) levels: non-A{beta}-accumulators (CSF-/PET-); early-A{beta}-accumulators (CSF+/PET-); and late-A{beta}-accumulators (CSF+/PET+). ExposureResting-state brain activity was assessed by functional magnetic resonance imaging (rsfMRI), whereas glymphatic function was estimated by the coupling between fMRI blood-oxygen-level-dependent (BOLD) signals and CSF movements. Main Outcomes and MeasuresCortical A{beta} accumulation measured by 18F-AV45 amyloid-positron emission tomography (PET), CSF A{beta}42, and total and phosphorylated tau protein levels in all participants. ResultsGlymphatic function assessed by fMRI was strongly ({rho} > 0.43, P < 0.042) associated with various markers of protein aggregation in early A{beta} accumulators in whom A{beta} just begins to accumulate cortically in the DMN. Among these early accumulators, the preferential A{beta} accumulation in the DMN regions in the subsequent two years was correlated with lower gBOLD signal ({rho} = 0.51, P = 0.027) and lower local glymphatic function ({rho} = 0.48, P = 0.041) in the same regions at baseline. Conclusions and RelevanceResting-state global brain activity and related glymphatic function are linked to A{beta} pathology, particularly its preferential deposition in the DMN at the earliest AD stages. This suggests potential novel early therapeutic directions that might provide disease modification. KO_SCPLOWEYC_SCPLOW PO_SCPLOWOINTSC_SCPLOWO_ST_ABSQuestionC_ST_ABSWhy does the {beta}-amyloid (A{beta}) plaque deposit preferentially in the default mode network (DMN) regions at early preclinical stages of Alzheimers disease? FindingsIn this analytic observational cohort study with 144 subjects, we found that the preferential reduction of global resting-state brain activity in the DMN, as well as its coupling with cerebrospinal fluid movement, was significantly correlated with the preferential A{beta} accumulation in these DMN regions among 19 subjects with early A{beta} accumulation. MeaningResting-state global brain activity plays a role in the early A{beta} accumulation in the DMN, presumably due to its involvement in glymphatic clearance.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Han, F., Liu, X., Mailman, R. B., Huang, X.. 2022-07-25. Early β-amyloid accumulation and hypoconnectivity in the default mode network are related to its disengagement from global brain activity. https://doi.org/10.1101/2022.07.24.501309

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Rab10 and Arhgef7 interact to promote axon extension by linking vesicle supply and exocytosis

The formation of functional neural circuits begins with the extension of a single axon by immature neurons. Axon elongation requires an expansion of the plasma membrane that depends on the polarization of vesicle trafficking and exocytosis. It is not completely understood how the increased transport of vesicles into the growing axon is linked to their subsequent insertion into the plasma membrane. An analysis of early stages of neuronal differentiation indicates that an asymmetry in neurite length precedes axon specification and the accumulation of PPVs in the nascent axon. We show that increasing the transport of vesicles in unpolarized neurons is sufficient to promote the extension of additional axons. This effect indicates that an increased supply of vesicles stimulates their subsequent insertion into the membrane to allow neurite growth. The link between vesicle transport and exocytosis is mediated by the interaction of Rab10 with Arhgef7. Rab10 stimulates Arhgef7 activity on PPVs as a GEF for Cdc42b to promote axon extension through exocyst-dependent exocytosis, suggesting that their interaction links the increased supply of PPVs to their exocytosis.

neuroscience↗

Subcellular Spatial Profiling Unveils Links Between Neuritic Plaques with Selective Tau Vulnerability in Alzheimer's Disease

Alzheimer's disease (AD) features widespread extracellular amyloid-{beta} plaques but selective intraneuronal tau accumulation in cortical layers II/III and V, while layer IV remains relatively resistant. Here, we combined subcellular spatial transcriptomics with co-registered A{beta} and pTau immunohistochemistry to determine why neurons exposed to comparable plaque-associated pathology differ in somatic pTau accumulation. Plaque-associated neuritic stress occurred similarly across layers, but layer IV neurons showed attenuated pTau accumulation and reduced somatic expression of a shared neurite-soma stress program involving DCTN1, CALM3, NORAD, and PIN1. Trajectory analysis within layers identified tau-vulnerable and resistant neuronal states implicating calcium signaling, retrograde transport, and lysosomal function. Notably, astrocytic APOE-neuronal LRP1 co-expression increased significantly along the pTau-vulnerable trajectory, and APOE {epsilon}4 was associated with stronger coupling of local plaque pathology to pTau-associated molecular programs. These findings reveal neuronal programs and neuron-glia interactions underlying selective tau vulnerability and resistance in AD, highlighting potential tau-targeting therapeutics.

neuroscience↗

Widespread oscillatory suppression in autism persists in the absence of psychotropic medication.

Purpose: Investigate the neural oscillatory activity associated with autism spectrum disorder (ASD) using electroencephalographic (EEG) recordings in children and adolescents. Compare the corresponding oscillatory power between ASD patients taking psychotropic medication with a drug-naive group. Methods: ASD diagnosis was done using DSM-IV and CARS (Childhood Autism Rating Scale). EEG recordings employed 22 scalp electrodes (10/20 system). ASD vs. neurotypical groups were matched for sex and age (5 females; average age: ~10 years old). We analyzed the resting state (eyes open) EEG power spectrum during ~2-minute recordings. The multitaper FFT method was used to estimate spectral power for the delta, theta, alpha, beta and gamma frequency bands. We pooled together data from several electrodes to compute comprehensive power spectra and assess the oscillatory behavior of macro brain regions. Results: We observed widespread (~4Hz - 20Hz) oscillatory suppression comprising the theta, alpha and beta frequency bands. The most widespread and robust ASD-associated power suppression was in the high theta and alpha bands. Delta and gamma bands showed no significant power change for any of the brain regions studied. Results from a subgroup of patients (N = 9) who never used psychotropics confirmed these findings, indicating that they are not an artifact of medication. Conclusion: Suppression in theta, alpha and beta oscillations may offer insights into the neurophysiological underpinnings of autism and could be used as an accessible and comprehensive tool in ASD diagnosis, regardless of the patients being or not on medication.

neuroscience↗